Profile

PhD, Sapienza - Università di Roma
MSc, Mario Negri Institute for Pharmacological Research


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Stravalaci M, Tapella L, Beeg M, Rossi A, Joshi P, Pizzi E, Mazzanti M, Balducci C, Forloni G, Biasini E, Salmona M, Diomede L, Chiesa R, Gobbi M. The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-ß Oligomers. J Alzheimers Dis. 2016 07 06; 53(4):1485-97. PMID: 27392850; DOI: 10.3233/JAD-150882;
     
  2. Sempou E, Biasini E, Pinzón-Olejua A, Harris DA, Málaga-Trillo E. Activation of zebrafish Src family kinases by the prion protein is an amyloid-ß-sensitive signal that prevents the endocytosis and degradation of E-cadherin/ß-catenin complexes in vivo. Mol Neurodegener. 2016 Feb 09; 11:18.View Related Profiles. PMID: 26860872; PMCID: PMC4748561; DOI: 10.1186/s13024-016-0076-5;
     
  3. Vercelli A, Biggi S, Sclip A, Repetto IE, Cimini S, Falleroni F, Tomasi S, Monti R, Tonna N, Morelli F, Grande V, Stravalaci M, Biasini E, Marin O, Bianco F, di Marino D, Borsello T. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury. Cell Death Dis. 2015; 6:e1854. PMID: 26270349; PMCID: PMC4558515; DOI: 10.1038/cddis.2015.226;
     
  4. Iraci N, Stincardini C, Barreca ML, Biasini E. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases. Virus Res. 2015 Sep 2; 207:62-8. PMID: 25456402; DOI: 10.1016/j.virusres.2014.10.015;
     
  5. Botto L, Cunati D, Coco S, Sesana S, Bulbarelli A, Biasini E, Colombo L, Negro A, Chiesa R, Masserini M, Palestini P. Role of lipid rafts and GM1 in the segregation and processing of prion protein. PLoS One. 2014; 9(5):e98344. PMID: 24859148; PMCID: PMC4032283; DOI: 10.1371/journal.pone.0098344;
     
  6. Tapella L, Stravalaci M, Bastone A, Biasini E, Gobbi M, Chiesa R. Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases. Biochem J. 2013 Sep 15; 454(3):417-25. PMID: 23808898; DOI: 10.1042/BJ20130563;
     
  7. Biasini E, Unterberger U, Solomon IH, Massignan T, Senatore A, Bian H, Voigtlaender T, Bowman FP, Bonetto V, Chiesa R, Luebke J, Toselli P, Harris DA. A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity. J Neurosci. 2013 Feb 6; 33(6):2408-18.View Related Profiles. PMID: 23392670; PMCID: PMC3711660; DOI: 10.1523/JNEUROSCI.3406-12.2013;
     
  8. Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, La Vitola P, Messa M, Colombo L, Forloni G, Borsello T, Gobbi M, Harris DA. An N-terminal fragment of the prion protein binds to amyloid-ß oligomers and inhibits their neurotoxicity in vivo. J Biol Chem. 2013 Mar 15; 288(11):7857-66.View Related Profiles. PMID: 23362282; PMCID: PMC3597823; DOI: 10.1074/jbc.M112.423954;
     
  9. Biasini E, Harris DA. Targeting the cellular prion protein to treat neurodegeneration. Future Med Chem. 2012 Sep; 4(13):1655-8.View Related Profiles. PMID: 22924502; DOI: 10.4155/fmc.12.114;
     
  10. Turnbaugh JA, Unterberger U, Saá P, Massignan T, Fluharty BR, Bowman FP, Miller MB, Supattapone S, Biasini E, Harris DA. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). J Neurosci. 2012 Jun 27; 32(26):8817-30.View Related Profiles. PMID: 22745483; PMCID: PMC3433751; DOI: 10.1523/JNEUROSCI.1103-12.2012;
     
Showing 10 of 31 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.



Contact for Mentoring: